Author

J. Elisseeff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Deshpande· 1 shared A. Lebid· 1 shared A. Mageau· 1 shared A. S. Popel· 1 shared A. T. F. Bell· 1 shared A. Tam· 1 shared C. Jourdan Le Saux· 1 shared D. Cihakova· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Deshpande

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence

S. Zhang, L. Yuan, L. Danilova, G. Mo, Q. Zhu, A. Deshpande, A. T. F. Bell, J. Elisseeff, A. S. Popel, R. A. Anders, E. M. Jaffee, M. Yarchoan, E. J. Fertig, L. T. Kagohara

This study uses spatial transcriptomics to analyze HCC tumors treated with cabozantinib and nivolumab, identifying distinct immune and fibrotic mechanisms linked to response and recurrence.

bioRxiv · Jan 10, 2023Cancer Biology

Interleukin 17 and senescence regulate the foreign body response

L. Chung, D. Maestas, A. Lebid, A. Mageau, G. D. Rosson, X. Wu, M. T. Wolf, A. Tam, X. Wang, I. Vanderzee, J. I. Andorko, R. Narain, K. Sadtler, H. Fan, D. Cihakova, , J. Elisseeff

This study identifies IL17 and senescence as regulators of the foreign body response, showing their roles in fibrosis and potential as therapeutic targets.

bioRxiv · Apr 11, 2019Immunology